By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celladon Corporation 

c/o Enterprise Partners Venture Capital
2223 Avenida de la Playa, Suite 300
La Jolla  California  92037  U.S.A.
Phone: 858-731-0241 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Celladon Corporation Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights 3/31/2015 6:55:23 AM
Celladon Corporation To Report Fourth Quarter And Fiscal 2014 Results On March 31 3/26/2015 12:18:27 PM
Novasep And Celladon Corporation Execute MYDICAR API Supply Agreement 3/25/2015 7:32:00 AM
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/16/2015 7:29:22 AM
Novasep Selected To Commercially Biomanufacture Celladon Corporation's Mydicar API 2/17/2015 10:57:24 AM
Celladon Corporation To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 8:35:11 AM
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/9/2015 7:47:40 AM
Celladon Corporation Conducts Initial Scale Up Of Manufacturing Process For MYDICAR To Commercial Scale 1/5/2015 7:21:03 AM
Celladon Corporation Added To NASDAQ Biotechnology Index 12/16/2014 8:02:23 AM
Celladon Corporation To Present At 11th Global Cardio Vascular Clinical Trial Forum 12/5/2014 10:28:22 AM
123456789
//-->